Anuh Pharma Limited has submitted to the Exchange regarding the approval of Un-audited Financial Results for the period ended September 30, 2025 and Adoption of revised policies of the Company.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Limited has submitted its un-audited financial results for the quarter/half-year ended September 30, 2025 to the stock exchange. The Board has also approved the adoption of revised company policies. No specific financial figures, segment details, or year-on-year comparisons are disclosed in this filing headline. The results remain un-audited, meaning final audited numbers may differ after statutory review.
This is a routine regulatory filing disclosing Q2/H1 FY26 results and policy updates. Without detailed numbers in the headline, investors should review the full financial result document for actual revenue, profit, and margin figures before drawing conclusions about the stock's outlook.